Page last updated: 2024-09-05

sb 203580 and Esophagitis, Reflux

sb 203580 has been researched along with Esophagitis, Reflux in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, X; Li, GX; Li, ZS; Liu, G; Liu, J; Zhang, L; Zou, DW	1

Other Studies

1 other study(ies) available for sb 203580 and Esophagitis, Reflux

Article	Year
Inhibition of p38 MAPK activation attenuates esophageal mucosal damage in a chronic model of reflux esophagitis. Neurogastroenterology and motility, 2015, Volume: 27, Issue:11 Topics: Animals; Blotting, Western; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Esophagitis, Peptic; Esophagus; Imidazoles; Immunohistochemistry; Male; Mucous Membrane; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction	2015

Article

Year

Inhibition of p38 MAPK activation attenuates esophageal mucosal damage in a chronic model of reflux esophagitis.

Neurogastroenterology and motility, 2015, Volume: 27, Issue:11

Topics: Animals; Blotting, Western; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Esophagitis, Peptic; Esophagus; Imidazoles; Immunohistochemistry; Male; Mucous Membrane; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction

2015